Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1

Hepatology

Volumn 48, Issue 5, 2008, Pages 1467-1476

  Martin Lluesma, Silvia ^a   Schaeffer, Céline ^a   Robert, Eva Isabelle ^a   van Breugel, Pieter Cornelis ^a   Leupin, Olivier ^a   Hantz, Oliver ^b   Strubin, Michael ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DNA BINDING PROTEIN 1; HEPATITIS B VIRUS X PROTEIN; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; HEPATITIS B ANTIGEN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN HEPG2; CELL VIABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; GENOMIC INSTABILITY; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER REGENERATION; MITOSIS SPINDLE; MULTINUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; ULTRAVIOLET RADIATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; CHROMOSOME ABERRATION; DISEASE COURSE; DNA DAMAGE; DRUG EFFECT; GENETICS; HELA CELL; HEPATITIS B; HUMAN CHROMOSOME; LIVER TUMOR; PATHOPHYSIOLOGY; PHYSIOLOGY; REPORTER GENE; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DISEASE PROGRESSION; DNA DAMAGE; DNA-BINDING PROTEINS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HEPATITIS B ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; TRANS-ACTIVATORS;

EID: 56149087784     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22542     Document Type: Article

References (37)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917.
2. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol 2004;78:12725-12734.
3. Tang H, Oishi N, Kaneko S, Murakami S. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci 2006;97:977-983.
4. Cougot D, Neuveut C, Buendia MA. HBV induced carcinogenesis. J Clin Virol 2005;34(suppl 1):S75-S78.
5. O'connell BC, Harper JW. Ubiquitin proteasome system (UPS): What can chromatin do for you? Curr Opin Cell Biol 2007;19:206-214.
6. Leupin O, Bontron S, Schaeffer C, Strubin M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 2005;79:4238-4245.
7. Bontron S, Lin-Marq N, Strubin M. Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2. J Biol Chem 2002;277:38847-38854.
8. Sitterlin D, Bergametti F, Transy C. UVDDB p127-binding modulates activities and intracellular distribution of hepatitis B virus X protein. Oncogene 2000;19:4417-4426.
9. Leupin O, Bontron S, Strubin M. Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J Virol 2003;77:6274-6283.
10. Martin-Lluesma S, Stucke VM, Nigg EA. Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2. Science 2002;297:2267-2270.
11. Gripon P, Rumin S, Urban S, Le SJ, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002;99:15655-15660.
12. Prasanth SG, Prasanth KV, Siddiqui K, Spector DL, Stillman B. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J 2004;23:2651-2663.
13. Gruss OJ, Wittmann M, Yokoyama H, Pepperkok R, Kufer T, Sillje H, et al. Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells. Nat Cell Biol 2002;4:871-879.
14. Nakamura M, Zhou XZ, Kishi S, Kosugi I, Tsutsui Y, Lu KP. A specific interaction between the telomeric protein Pin2/TRF1 and the mitotic spindle. Curr Biol 2001;11:1512-1516.
15. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: Aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-785.
16. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999;59:4375-4382.
17. Blow JJ, Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 2005;6:476-486.
18. Lee S, Tarn C, Wang WH, Chen S, Hullinger RL, Andrisani OM. Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines. J Biol Chem 2002;277:8730-8740.
19. Livezey KW, Negorev D, Simon D. Increased chromosomal alterations and micronuclei formation in human hepatoma HepG2 cells transfected with the hepatitis B virus HBX gene. Mutat Res 2002;505:63-74.
20. Forgues M, Difilippantonio MJ, Linke SP, Ried T, Nagashima K, Feden J, et al. Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol 2003; 23:5282-5292.
21. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK, et al. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/ extracellular signal-regulated kinase-mitogen-activated protein pathway. Mol Cancer Res 2004;2:159-169.
22. Wen Y, Golubkov VS, Strongin AY, Jiang W, Reed JC. Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem 2008;283: 2793-2803.
23. Kim S, Park SY, Yong H, Famulski JK, Chae S, Lee JH, et al. HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 2008;27:3457-3464.
24. Chen HY, Tang NH, Lin N, Chen ZX, Wang XZ. Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses. Hepatol Res 2008;38:174-182.
25. Wong C, Stearns T. Centrosome number is controlled by a centrosome-intrinsic block to reduplication. Nat Cell Biol 2003;5:539-544.
26. Prasanth SG, Prasanth KV, Stillman B. Orc6 involved in DNA replication, chromosome segregation, and cytokinesis. Science 2002;297:1026-1031.
27. Venkitaraman AR. Medicine: Aborting the birth of cancer. Nature 2005; 434:829-830.
28. Jin J, Arias EE, Chen J, Harper JW, Walter JC. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 2006;23:709-721.
29. Lovejoy CA, Lock K, Yenamandra A, Cortez D. DDB1 maintains genome integrity through regulation of Cdt1. Mol Cell Biol 2006;26:7977-7990.
30. Precious B, Childs K, Fitzpatrick-Swallow V, Goodbourn S, Randall RE. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 2005;79:13434-13441.
31. Dehart JL, Planelles V. Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. J Virol 2008;82: 1066-1072.
32. Belzile JP, Duisit G, Rougeau N, Mercier J, Finzi A, Cohen EA. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4A(VPRBP) E3 ubiquitin ligase. PLoS Pathog 2007;3:e85.
33. Dehart JL, Zimmerman ES, Ardon O, Monteiro-Filho CM, Arganaraz ER, Planelles V. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virol J 2007;4:57.
34. Le RE, Belaidouni N, Estrabaud E, Morel M, Rain JC, Transy C, et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 2007;6:182-188.
35. Tan L, Ehrlich E, Yu XF. DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest. J Virol 2007;81: 10822-10830.
36. Tralhao JG, Roudier J, Morosan S, Giannini C, Tu H, Goulenok C, et al. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: An alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A 2002;99:6991-6996.
37. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120: 1763-1773.